Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.24 +6.9% TUNG 1.72 +1.8% LGO 0.990 −4.8% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.26 −2.6% SGZ 0.045 +0.0% S 0.140 +16.7% GRSL 0.315 −1.6% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.51 −1.4% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.24 +6.9% TUNG 1.72 +1.8% LGO 0.990 −4.8% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.26 −2.6% SGZ 0.045 +0.0% S 0.140 +16.7% GRSL 0.315 −1.6% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.51 −1.4%
Financings Routine −

Avicanna Announces Closing of Non-Brokered Private Placement

Avicanna closes $600K dilutive placement at a premium to market, but cash runway remains precarious amid persistent burn.

By The Northwire Desk — AI Analysis Jun 12, 2026 · 17:30 AVCN · 0.125 AVICANNA INC. J
Executive Summary
  • Closing of a non-brokered private placement offering 4,000,014 units at $0.15 per unit.
  • Gross proceeds of approximately $600,002.
  • Each unit consists of one common share and a half warrant.
  • Warrants are exercisable at $0.20 per share until June 12, 2029.
  • Proceeds allocated to general working capital, G&A, production/manufacturing, and R&D/clinical development.
  • Subject to a four-month hold period and TSX approval.
Material Impact
  • The financing provides ~$600k in additional runway, extending operations by a few months given the ~$1M/quarter burn rate. It is a routine capital raise for a cash-burning micro-cap. The stock's -21% decline into the print shows the market was already pricing in dilution. The $0.15 placement price is a modest premium to the $0.11 market, but the issuance of warrants and ongoing cash needs limit upside. Not material.
AVCN · Price
Company Overview
  • Avicanna Inc. is a Canadian medical cannabis and biopharmaceutical company. Focus on proprietary cannabinoid formulations, MyMedi.ca platform, and clinical pipeline. Operations in Canada, Colombia, and international exports.
Read the original news release →

More from AVICANNA INC. J

Jun 30, 2026 · 17:30

Avicanna Announces Promotion of Nick Hilborn CPA CA to Chief Financial Officer

Management Jun 15, 2026 · 08:30

Splash's $300K strategic bet validates Avicanna's pivot, but liquidity and dilution overhangs keep the stock in a holding pattern.

M&A / Property May 14, 2026 · 07:30

Avicanna Revenue Growth Masks Profitability Regression as Liquidity Improves

Earnings May 08, 2026 · 07:30

Avicanna Announces Results of Annual General and Special Meeting

Regulatory May 01, 2026 · 20:46

Avicanna Announces Change in Board of Directors

Management Apr 28, 2026 · 07:28

U.S. Rescheduling Confirmed, but Liquidity Overhang Caps Immediate Upside

Regulatory